Prognostic Factors After Index Hospitalization for Heart Failure With Preserved Ejection Fraction

Abstract Heart failure with preserved ejection fraction (HFpEF) has a high clinical burden and constitutes approximately 20-30% of heart failure patients in Asia. Impaired global longitudinal strain (GLS), defined as an absolute value of <15.8%, has been shown to be a predictor of heart failure h...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 119; no. 12; pp. 2017 - 2020
Main Authors Huang, Weiting, MRCP, Chai, Siang Chew, MRCP, Lee, Shao Guang Sheldon, MRCP, MacDonald, Michael R., FESC, Leong, Kui Toh Gerard, FRCP
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.06.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Heart failure with preserved ejection fraction (HFpEF) has a high clinical burden and constitutes approximately 20-30% of heart failure patients in Asia. Impaired global longitudinal strain (GLS), defined as an absolute value of <15.8%, has been shown to be a predictor of heart failure hospitalization, cardiovascular death, and aborted cardiac arrest in HFpEF. We sought to validate this finding in our Asian cohort and identify other prognostic factors in HFpEF. In this cohort study, we included all patients with an index hospitalization for heart failure and left ventricular ejection fraction of more than 45%, between 1st January 2012 and 31st December 2012. All patients had follow-up for at least 3 years. In our study, the absolute value of mean GLS was impaired at 13.50±4.00%, while mean LVEF was 52.00±7.67%. In multivariate Cox regression, impaired GLS of absolute value <15.8% (hazard ratio 4.72, 95% CI 1.25-17.81, p=0.022), every unit increase in age-adjusted Charlson Comorbidity Index (hazard ratio 1.46, 95% CI 1.03-2.05, p=0.031) and low body mass index <18.5kg/m2 (hazard ratio 4.30, 95% CI 1.25-14.78, p=0.020) were associated with a shorter time to mortality over the three year period. Our study validates absolute GLS value of <15.8% to be a prognostic marker for HFpEF patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2017.03.032